ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
ESMO Colloquium
CD95L/Fas ligand selective inhibition: Rationale and clinical results
(ID 6223)
Lecture Time
19:38 - 19:53
Speakers
Wolfgang Wick
(Heidelberg, Germany)
Session Name
ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
18:30 - 20:00